H.C. Wainwright Downgrades Timber Pharmaceuticals (TMBR) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

August 28, 2023 6:11 AM EDT
Get Alerts TMBR Hot Sheet
Price: $0.34 --0%

Rating Summary:
    0 Buy, 1 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE

H.C. Wainwright analyst Raghuram Selvaraju downgraded Timber Pharmaceuticals (NYSE: TMBR) from Buy to Neutral.


For an analyst ratings summary and ratings history on Timber Pharmaceuticals click here. For more ratings news on Timber Pharmaceuticals click here.


Shares of Timber Pharmaceuticals closed at $3.03 yesterday.


You May Also Be Interested In





Related Categories

Downgrades